ID   ACDSB_HUMAN             Reviewed;         432 AA.
AC   P45954; B4DQ51; Q5SQN6; Q96CX7;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1995, sequence version 1.
DT   15-MAR-2017, entry version 181.
DE   RecName: Full=Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial;
DE            Short=SBCAD;
DE            EC=1.3.8.5;
DE   AltName: Full=2-methyl branched chain acyl-CoA dehydrogenase;
DE            Short=2-MEBCAD;
DE   AltName: Full=2-methylbutyryl-coenzyme A dehydrogenase;
DE            Short=2-methylbutyryl-CoA dehydrogenase;
DE   Flags: Precursor;
GN   Name=ACADSB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Liver;
RX   PubMed=7698750; DOI=10.1006/geno.1994.1617;
RA   Rozen R., Vockley J., Zhou L., Milos R., Willard J., Fu K.,
RA   Vicanek C., Low-Nang L., Torban E., Fournier B.;
RT   "Isolation and expression of a cDNA encoding the precursor for a novel
RT   member (ACADSB) of the acyl-CoA dehydrogenase gene family.";
RL   Genomics 24:280-287(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=11013134; DOI=10.1086/303105;
RA   Andresen B.S., Christensen E., Corydon T.J., Bross P., Pilgaard B.,
RA   Wanders R.J.A., Ruiter J.P.N., Simonsen H., Winter V., Knudsen I.,
RA   Schroeder L.D., Gregersen N., Skovby F.;
RT   "Isolated 2-methylbutyrylglycinuria caused by short/branched-chain
RT   acyl-CoA dehydrogenase deficiency: identification of a new enzyme
RT   defect, resolution of its molecular basis, and evidence for distinct
RT   acyl-CoA dehydrogenases in isoleucine and valine metabolism.";
RL   Am. J. Hum. Genet. 67:1095-1103(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Esophagus, and Mammary gland;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   LYS-13.
RC   TISSUE=Mammary gland;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 6-432 (ISOFORM 1), AND
RP   VARIANTS LYS-13 AND VAL-316.
RC   TISSUE=Skeletal muscle;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [8]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-284, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-183, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 52-432 IN COMPLEX WITH FAD
RP   AND SUBSTRATE ANALOG, COFACTOR, AND SUBUNIT.
RG   Structural genomics consortium (SGC);
RT   "Crystal structure of human short-branched chain acyl-CoA
RT   dehydrogenase.";
RL   Submitted (FEB-2009) to the PDB data bank.
RN   [13]
RP   VARIANT SBCADD PHE-255.
RX   PubMed=10832746; DOI=10.1203/00006450-200006000-00025;
RA   Gibson K.M., Burlingame T.G., Hogema B., Jakobs C., Schutgens R.B.H.,
RA   Millington D., Roe C.R., Roe D.S., Sweetman L., Steiner R.D.,
RA   Linck L., Pohowalla P., Sacks M., Kiss D., Rinaldo P., Vockley J.;
RT   "2-methylbutyryl-coenzyme A dehydrogenase deficiency: a new inborn
RT   error of L-isoleucine metabolism.";
RL   Pediatr. Res. 47:830-833(2000).
RN   [14]
RP   VARIANT SBCADD PHE-255.
RX   PubMed=16317551; DOI=10.1007/s00439-005-0070-4;
RA   Madsen P.P., Kibaek M., Roca X., Sachidanandam R., Krainer A.R.,
RA   Christensen E., Steiner R.D., Gibson K.M., Corydon T.J., Knudsen I.,
RA   Wanders R.J., Ruiter J.P.N., Gregersen N., Andresen B.S.;
RT   "Short/branched-chain acyl-CoA dehydrogenase deficiency due to an
RT   IVS3+3A>G mutation that causes exon skipping.";
RL   Hum. Genet. 118:680-690(2006).
CC   -!- FUNCTION: Has greatest activity toward short branched chain acyl-
CC       CoA derivative such as (s)-2-methylbutyryl-CoA, isobutyryl-CoA,
CC       and 2-methylhexanoyl-CoA as well as toward short straight chain
CC       acyl-CoAs such as butyryl-CoA and hexanoyl-CoA. Can use valproyl-
CC       CoA as substrate and may play a role in controlling the metabolic
CC       flux of valproic acid in the development of toxicity of this
CC       agent.
CC   -!- CATALYTIC ACTIVITY: Acyl-CoA + acceptor = 2,3-dehydroacyl-CoA +
CC       reduced acceptor.
CC   -!- CATALYTIC ACTIVITY: 2-methylbutanoyl-CoA + electron-transfer
CC       flavoprotein = (E)-2-methylbut-2-enoyl-CoA + reduced electron-
CC       transfer flavoprotein + H(+).
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692; Evidence={ECO:0000269|Ref.12};
CC   -!- PATHWAY: Lipid metabolism; mitochondrial fatty acid beta-
CC       oxidation.
CC   -!- SUBUNIT: Homotetramer. {ECO:0000269|Ref.12}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion matrix.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P45954-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P45954-2; Sequence=VSP_055778;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Ubiquitous.
CC   -!- DISEASE: Short/branched-chain acyl-CoA dehydrogenase deficiency
CC       (SBCADD) [MIM:610006]: Autosomal recessive disorder and consists
CC       of a defect in catabolism of L-isoleucine which is characterized
CC       by an increase of 2-methylbutyrylglycine and 2-
CC       methylbutyrylcarnitine in blood and urine. Affected individuals
CC       have seizures and psychomotor delay as the main clinical features.
CC       {ECO:0000269|PubMed:10832746, ECO:0000269|PubMed:16317551}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the acyl-CoA dehydrogenase family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U12778; AAA74424.1; -; mRNA.
DR   EMBL; AF260678; AAF97921.1; -; Genomic_DNA.
DR   EMBL; AF260668; AAF97921.1; JOINED; Genomic_DNA.
DR   EMBL; AF260669; AAF97921.1; JOINED; Genomic_DNA.
DR   EMBL; AF260670; AAF97921.1; JOINED; Genomic_DNA.
DR   EMBL; AF260671; AAF97921.1; JOINED; Genomic_DNA.
DR   EMBL; AF260672; AAF97921.1; JOINED; Genomic_DNA.
DR   EMBL; AF260673; AAF97921.1; JOINED; Genomic_DNA.
DR   EMBL; AF260674; AAF97921.1; JOINED; Genomic_DNA.
DR   EMBL; AF260675; AAF97921.1; JOINED; Genomic_DNA.
DR   EMBL; AF260676; AAF97921.1; JOINED; Genomic_DNA.
DR   EMBL; AF260677; AAF97921.1; JOINED; Genomic_DNA.
DR   EMBL; AK298638; BAG60813.1; -; mRNA.
DR   EMBL; AK314241; BAG36909.1; -; mRNA.
DR   EMBL; AL731666; CAI10847.1; -; Genomic_DNA.
DR   EMBL; AC012391; CAI10847.1; JOINED; Genomic_DNA.
DR   EMBL; AC073585; CAI10847.1; JOINED; Genomic_DNA.
DR   EMBL; CH471066; EAW49291.1; -; Genomic_DNA.
DR   EMBL; BC013756; AAH13756.1; -; mRNA.
DR   EMBL; AL831821; CAD38535.2; -; mRNA.
DR   CCDS; CCDS7634.1; -. [P45954-1]
DR   CCDS; CCDS81518.1; -. [P45954-2]
DR   PIR; A55680; A55680.
DR   RefSeq; NP_001317103.1; NM_001330174.1. [P45954-2]
DR   RefSeq; NP_001600.1; NM_001609.3. [P45954-1]
DR   UniGene; Hs.81934; -.
DR   PDB; 2JIF; X-ray; 2.00 A; A/B/C/D=52-432.
DR   PDBsum; 2JIF; -.
DR   ProteinModelPortal; P45954; -.
DR   SMR; P45954; -.
DR   BioGrid; 106554; 14.
DR   IntAct; P45954; 7.
DR   STRING; 9606.ENSP00000357873; -.
DR   DrugBank; DB00167; L-Isoleucine.
DR   DrugBank; DB00313; Valproic Acid.
DR   SwissLipids; SLP:000001415; -.
DR   iPTMnet; P45954; -.
DR   PhosphoSitePlus; P45954; -.
DR   SwissPalm; P45954; -.
DR   BioMuta; ACADSB; -.
DR   DMDM; 1168283; -.
DR   EPD; P45954; -.
DR   PaxDb; P45954; -.
DR   PeptideAtlas; P45954; -.
DR   PRIDE; P45954; -.
DR   DNASU; 36; -.
DR   Ensembl; ENST00000358776; ENSP00000357873; ENSG00000196177. [P45954-1]
DR   Ensembl; ENST00000368869; ENSP00000357862; ENSG00000196177. [P45954-2]
DR   GeneID; 36; -.
DR   KEGG; hsa:36; -.
DR   UCSC; uc001lhb.4; human. [P45954-1]
DR   CTD; 36; -.
DR   DisGeNET; 36; -.
DR   GeneCards; ACADSB; -.
DR   HGNC; HGNC:91; ACADSB.
DR   HPA; HPA041458; -.
DR   MalaCards; ACADSB; -.
DR   MIM; 600301; gene.
DR   MIM; 610006; phenotype.
DR   neXtProt; NX_P45954; -.
DR   OpenTargets; ENSG00000196177; -.
DR   Orphanet; 79157; 2-methylbutyryl-CoA dehydrogenase deficiency.
DR   PharmGKB; PA24427; -.
DR   eggNOG; KOG0139; Eukaryota.
DR   eggNOG; COG1960; LUCA.
DR   GeneTree; ENSGT00760000119007; -.
DR   HOGENOM; HOG000131659; -.
DR   HOVERGEN; HBG000224; -.
DR   InParanoid; P45954; -.
DR   KO; K09478; -.
DR   OMA; GQTTSKC; -.
DR   OrthoDB; EOG091G04BS; -.
DR   PhylomeDB; P45954; -.
DR   TreeFam; TF105055; -.
DR   Reactome; R-HSA-70895; Branched-chain amino acid catabolism.
DR   UniPathway; UPA00660; -.
DR   ChiTaRS; ACADSB; human.
DR   EvolutionaryTrace; P45954; -.
DR   GenomeRNAi; 36; -.
DR   PRO; PR:P45954; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000196177; -.
DR   CleanEx; HS_ACADSB; -.
DR   ExpressionAtlas; P45954; baseline and differential.
DR   Genevisible; P45954; HS.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005759; C:mitochondrial matrix; TAS:Reactome.
DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.
DR   GO; GO:0003995; F:acyl-CoA dehydrogenase activity; EXP:Reactome.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IEA:InterPro.
DR   GO; GO:0009083; P:branched-chain amino acid catabolic process; TAS:Reactome.
DR   GO; GO:0006631; P:fatty acid metabolic process; TAS:ProtInc.
DR   Gene3D; 1.10.540.10; -; 1.
DR   InterPro; IPR006089; Acyl-CoA_DH_CS.
DR   InterPro; IPR006091; Acyl-CoA_Oxase/DH_cen-dom.
DR   InterPro; IPR009075; AcylCo_DH/oxidase_C.
DR   InterPro; IPR013786; AcylCoA_DH/ox_N.
DR   InterPro; IPR009100; AcylCoA_DH/oxidase_NM_dom.
DR   Pfam; PF00441; Acyl-CoA_dh_1; 1.
DR   Pfam; PF02770; Acyl-CoA_dh_M; 1.
DR   Pfam; PF02771; Acyl-CoA_dh_N; 1.
DR   SUPFAM; SSF47203; SSF47203; 1.
DR   SUPFAM; SSF56645; SSF56645; 1.
DR   PROSITE; PS00072; ACYL_COA_DH_1; 1.
DR   PROSITE; PS00073; ACYL_COA_DH_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Complete proteome;
KW   Disease mutation; FAD; Fatty acid metabolism; Flavoprotein;
KW   Lipid metabolism; Mitochondrion; Oxidoreductase; Phosphoprotein;
KW   Polymorphism; Reference proteome; Transit peptide.
FT   TRANSIT       1     33       Mitochondrion.
FT   CHAIN        34    432       Short/branched chain specific acyl-CoA
FT                                dehydrogenase, mitochondrial.
FT                                /FTId=PRO_0000000519.
FT   NP_BIND     174    183       FAD. {ECO:0000269|Ref.12}.
FT   NP_BIND     207    209       FAD. {ECO:0000269|Ref.12}.
FT   NP_BIND     387    391       FAD; shared with dimeric partner.
FT                                {ECO:0000269|Ref.12}.
FT   NP_BIND     416    418       FAD. {ECO:0000269|Ref.12}.
FT   REGION      229    230       Substrate binding.
FT   REGION      291    294       Substrate binding.
FT   ACT_SITE    414    414       Proton acceptor. {ECO:0000250}.
FT   BINDING     183    183       Substrate; via carbonyl oxygen.
FT   BINDING     283    283       Substrate.
FT   BINDING     319    319       FAD; shared with dimeric partner.
FT                                {ECO:0000269|Ref.12}.
FT   BINDING     330    330       FAD; shared with dimeric partner.
FT                                {ECO:0000269|Ref.12}.
FT   BINDING     415    415       Substrate; via amide nitrogen.
FT   MOD_RES      70     70       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q9DBL1}.
FT   MOD_RES      70     70       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q9DBL1}.
FT   MOD_RES     183    183       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     284    284       N6-acetyllysine; alternate.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     284    284       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q9DBL1}.
FT   MOD_RES     426    426       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q9DBL1}.
FT   VAR_SEQ       1    102       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_055778.
FT   VARIANT      13     13       R -> K (in dbSNP:rs12263012).
FT                                {ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:17974005}.
FT                                /FTId=VAR_048177.
FT   VARIANT     209    209       S -> G (in dbSNP:rs1799823).
FT                                /FTId=VAR_014749.
FT   VARIANT     255    255       L -> F (in SBCADD; dbSNP:rs137852649).
FT                                {ECO:0000269|PubMed:10832746,
FT                                ECO:0000269|PubMed:16317551}.
FT                                /FTId=VAR_013010.
FT   VARIANT     316    316       I -> V (in dbSNP:rs1131430).
FT                                {ECO:0000269|PubMed:17974005}.
FT                                /FTId=VAR_048178.
FT   VARIANT     376    376       E -> G (in dbSNP:rs12357783).
FT                                /FTId=VAR_048179.
FT   HELIX        59     75       {ECO:0000244|PDB:2JIF}.
FT   HELIX        77     79       {ECO:0000244|PDB:2JIF}.
FT   HELIX        80     86       {ECO:0000244|PDB:2JIF}.
FT   HELIX        91     99       {ECO:0000244|PDB:2JIF}.
FT   TURN        100    103       {ECO:0000244|PDB:2JIF}.
FT   STRAND      104    107       {ECO:0000244|PDB:2JIF}.
FT   HELIX       109    111       {ECO:0000244|PDB:2JIF}.
FT   HELIX       118    129       {ECO:0000244|PDB:2JIF}.
FT   HELIX       133    144       {ECO:0000244|PDB:2JIF}.
FT   HELIX       146    153       {ECO:0000244|PDB:2JIF}.
FT   HELIX       156    168       {ECO:0000244|PDB:2JIF}.
FT   STRAND      172    175       {ECO:0000244|PDB:2JIF}.
FT   STRAND      181    184       {ECO:0000244|PDB:2JIF}.
FT   HELIX       185    187       {ECO:0000244|PDB:2JIF}.
FT   STRAND      191    195       {ECO:0000244|PDB:2JIF}.
FT   STRAND      198    209       {ECO:0000244|PDB:2JIF}.
FT   TURN        210    213       {ECO:0000244|PDB:2JIF}.
FT   STRAND      215    223       {ECO:0000244|PDB:2JIF}.
FT   HELIX       225    231       {ECO:0000244|PDB:2JIF}.
FT   STRAND      232    238       {ECO:0000244|PDB:2JIF}.
FT   STRAND      244    246       {ECO:0000244|PDB:2JIF}.
FT   STRAND      252    254       {ECO:0000244|PDB:2JIF}.
FT   STRAND      260    271       {ECO:0000244|PDB:2JIF}.
FT   HELIX       272    274       {ECO:0000244|PDB:2JIF}.
FT   STRAND      275    278       {ECO:0000244|PDB:2JIF}.
FT   HELIX       282    318       {ECO:0000244|PDB:2JIF}.
FT   HELIX       326    328       {ECO:0000244|PDB:2JIF}.
FT   HELIX       330    358       {ECO:0000244|PDB:2JIF}.
FT   HELIX       364    389       {ECO:0000244|PDB:2JIF}.
FT   HELIX       390    394       {ECO:0000244|PDB:2JIF}.
FT   HELIX       400    407       {ECO:0000244|PDB:2JIF}.
FT   HELIX       408    411       {ECO:0000244|PDB:2JIF}.
FT   TURN        412    414       {ECO:0000244|PDB:2JIF}.
FT   HELIX       417    431       {ECO:0000244|PDB:2JIF}.
SQ   SEQUENCE   432 AA;  47485 MW;  1EB5F894B1944E99 CRC64;
     MEGLAVRLLR GSRLLRRNFL TCLSSWKIPP HVSKSSQSEA LLNITNNGIH FAPLQTFTDE
     EMMIKSSVKK FAQEQIAPLV STMDENSKME KSVIQGLFQQ GLMGIEVDPE YGGTGASFLS
     TVLVIEELAK VDASVAVFCE IQNTLINTLI RKHGTEEQKA TYLPQLTTEK VGSFCLSEAG
     AGSDSFALKT RADKEGDYYV LNGSKMWISS AEHAGLFLVM ANVDPTIGYK GITSFLVDRD
     TPGLHIGKPE NKLGLRASST CPLTFENVKV PEANILGQIG HGYKYAIGSL NEGRIGIAAQ
     MLGLAQGCFD YTIPYIKERI QFGKRLFDFQ GLQHQVAHVA TQLEAARLLT YNAARLLEAG
     KPFIKEASMA KYYASEIAGQ TTSKCIEWMG GVGYTKDYPV EKYFRDAKIG TIYEGASNIQ
     LNTIAKHIDA EY
//
